Aggregation and structure of amyloid β-protein

Area of Science:

• Neurodegenerative Disorders
• Molecular Biology
• Biochemistry

Background:

• Alzheimer's disease (AD) is a common age-related neurodegenerative disorder.
• Key pathological hallmarks include amyloid beta-protein (Aβ) plaques and tau tangles.
• Aβ aggregation into oligomers, protofibrils, and fibrils is central to AD pathogenesis.

Purpose of the Study:

• To review the structural properties and aggregation mechanisms of Aβ.
• To highlight the role of Aβ in Alzheimer's disease.
• To summarize recent advancements in understanding Aβ structure and aggregation.

Main Methods:

• Review of existing literature and studies.
• Analysis of data from genetic studies, biochemical assays, and animal models.
• Integration of findings from nuclear magnetic resonance (NMR) and cryo-electron microscopy (cryo-EM).

Main Results:

• Aβ aggregation is a complex process yielding diverse structures.
• Recent studies using NMR and cryo-EM provide detailed insights into fibril extension and secondary nucleation.
• Structural polymorphism of Aβ fibrils under various conditions, including in the brain, has been elucidated.

Conclusions:

• Understanding Aβ structure and aggregation is critical for elucidating AD pathogenesis.
• Advanced imaging and spectroscopic techniques are crucial for detailed structural analysis.
• Continued research into Aβ aggregation mechanisms may lead to therapeutic strategies for Alzheimer's disease.